Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3701 - 3725 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA02
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261629 1578.886893 C74H134N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC04
  • Forssman antigen(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260183 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD04
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Para-Forssman x3b(d18:1/22:0)
44260191 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC04
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260391 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD04
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260399 1513.923217 C74H135N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC04
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260503 1513.923217 C74H135N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE04
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260519 1513.923217 C74H135N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO04
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260599 1513.923217 C74H135N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ04
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260687 1513.923217 C74H135N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK04
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • nLc5Cer(d18:1/22:0)
44261055 1513.923217 C74H135N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN04
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • P antigen(d18:1/22:0)
44261287 1513.923217 C74H135N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE04
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261423 1513.923217 C74H135N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD04
  • Forssman-like iGb4(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261863 1513.923217 C74H135N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO04
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261927 1513.923217 C74H135N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG04
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261679 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU08
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260331 1469.922154 C74H135NO27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM08
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260267 1485.917069 C74H135NO28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN03
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260270 1565.891644 C74H135NO33
Diacylglycerophosphoinositolglycans LMGP15010204
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/18:0)
126457572 1662.836908 C74H135O38P
Diacylglycerophosphoinositolglycans LMGP15010225
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/16:0)
126457593 1662.836908 C74H135O38P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI05
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260552 1484.933053 C74H136N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC05
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Lewis a(d18:1/24:0)
44260632 1484.933053 C74H136N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD05
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type I H antigen(d18:1/24:0)
44260640 1484.933053 C74H136N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB05
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Lex-5(d18:1/24:0)
44260984 1484.933053 C74H136N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD05
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type II antigen(d18:1/24:0)
44261000 1484.933053 C74H136N2O27

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024